Advanced Search
Contact | Corporate | Help

Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer

Sponsors:
  • Massachusetts General Hospital
  • Dana-Farber Cancer Institute
  • Abraxis BioScience Inc.
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Non-small Cell Lung Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: carboplatin
  • Drug: Abraxane
  • Drug: Avastin
Enrollment:
36

Additional information about NCT00642759.


SourceSolution © 2008-2012